Reven, APCER Life Sciences Partner for Upcoming COVID-19 Trial 

  • This topic is empty.
Viewing 1 post (of 1 total)
  • Author
    Posts
  • 10/05/2020 at 9:17 am #11092
    Colorado BioScience AssocationColorado BioScience Association
    Keymaster
    Reven will use APCER Life Sciences as its service provider in pharmacovigilance, quality assurance, regulatory assurance, and regulatory affairs for the clinical trial of its lead anti-inflammatory/anti-oxidant investigational drug product, Rejuveinix (RJX).
  • Author
    Posts
Viewing 1 post (of 1 total)
  • You must be logged in to reply to this topic.